Donepezil hydrochloride Tablets, USP are indicated for the treatment of dementia of the Alzheimer’s type. Efficacy has been demonstrated in patients with mild, moderate, and severe Alzheimer’s disease.

Use with Anticholinergics

Because of their mechanism of action, cholinesterase inhibitors have the potential to interfere with the activity of anticholinergic medications.

Use with Cholinomimetics and Other Cholinesterase Inhibitors

A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents, or cholinergic agonists such as bethanechol.

Donepezil Hydrochloride Tablets, USP

• Supplied as film-coated, round tablets containing 23 mg of Donepezil hydrochloride, USP.
• The 23 mg tablets are pink, round, biconvex tablets, debossed on one side with “hz” and “177” on the other side.

Packaging:

Bottles of 30 (NDC# 42658-130-01)
Bottles of 90 (NDC# 42658-130-04)

Storage:
Store at 20°C-25°C (68°-77°F). [See USP Controlled Room Temperature].